Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow.
Sun J. et al, (2024), Schizophrenia (Heidelb), 10
Changes in immunoglobulin levels during clozapine treatment in schizophrenia.
Griffiths K. et al, (2024), Brain Behav Immun, 115, 223 - 228
Positive and negative personality descriptors: UK dataset of self-referential valence, imageability and subjective frequency ratings of 300 adjectives for use in cognitive-emotional tasks
Raslescu A. et al, (2022), Data in Brief, 108831 - 108831
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.
Colwell MJ. et al, (2022), Transl Psychiatry, 12
Can You Feel the Burn? Using Neuroimaging to Illuminate the Mechanisms of Mindfulness Interventions for Pain.
Gillespie A. and Harmer CJ., (2022), Am J Psychiatry, 179, 705 - 707
Changes in immunoglobulin levels during clozapine treatment in schizophrenia
Griffiths K. et al, (2022)
Associations Between Statin Use and Negative Affective Bias During COVID-19: An Observational, Longitudinal UK Study Investigating Depression Vulnerability.
Gillespie AL. et al, (2022), Biol Psychiatry
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia.
Krajner F. et al, (2022), NPJ Schizophr, 8
Online behavioural activation during the COVID-19 pandemic decreases depression and negative affective bias.
Ruzickova T. et al, (2021), Psychol Med, 1 - 18
Translating the promise of 5HT4 receptor agonists for the treatment of depression.
Murphy SE. et al, (2021), Psychol Med, 51, 1111 - 1120
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia.
McQueen G. et al, (2021), Schizophr Bull, 47, 662 - 671
DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia.
Hannon E. et al, (2021), Elife, 10
Longitudinal DNA methylation changes associated with improvement of psychotic symptoms during clozapine treatment
Gillespie A. et al, (2020), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 31, S13 - S14
Risk factors for depression vulnerability during the COVID-19 pandemic: findings from the Oxford COSIE (COVID-19, Social Isolation and Emotion) Study
Gillespie A. et al, (2020), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 40, S417 - S418
Self-reported Rates of Abuse, Neglect, and Bullying Experienced by Transgender and Gender-Nonbinary Adolescents in China.
Peng K. et al, (2019), JAMA Netw Open, 2